Patients and caregivers know better than anyone what it is like to live with a serious disease.We listen.And we learn from people’s experiences.We work together to create medicines that address the needs of people living with disease and achieve the results that matter to them。

Novartis commitment to patients and caregivers

We recognize the importance of patients and caregivers understanding what they can expect from Novartis。

Learn more

 

管道管道和管道总站

 

1。阻遏，阻遏and，andunderstandingthe patient community perspective

2.Expandingaccesstoour medicines

3.Conducting可回收的，可回收的密封圈，密封圈

4.Recognizing the importance oftransparencyand，and恢复，恢复

Read more about our commitment to patients and caregivershere，here。

40+

Patient organizations represented

PDF0.6MB
78k+

Novartis associates own it asan aspiration*

doctor and nurse

置换成形

Novartis annually discloses monetary and non-monetary support to patient organizations around the globe by June30。

Learn more

 

Our commitment–reporting 2023 progress

 

90%

介质循环开关输入

People living with disease provided insights before first-in-human trials（healthy volunters）。

6 118

Patients reached through managed access programs

95%requests approved for50compounds in72countries-providing access to locally unlicensed Novartis medicines。

32

Clinical development programs

consulted people living with disease on the design and/or conduct of clinical trials。

197

Clinical trials

included patient reported outcomes（PRO）conducted in79countries。

266

简单尺寸

从Phase I-IV clinical trials sent to investigators to share with 40000 trial participants and posted onnovartis.com/clinicaltrials。

33.2 million

Patients

reached through access programs。

 

Clinical Trials

密封密封密封圈密封圈密封圈密封圈密封圈密封圈密封圈密封圈密封圈密封圈密封圈密封圈密封圈密封圈密封圈密封圈密封圈密封圈密封圈密封圈密封圈密封圈密封圈密封圈密封圈密封圈密封圈密封圈密封圈密封圈密封圈密封圈密封圈密封圈密封圈密封圈密封圈密封圈

About clinical trials

Clinical trials are scientific studies conducted to find better ways to prevent，screen for，diagnose or treat disease。
A doctor speaks with a patient

不受影响的密封圈

Novartis is currently conducting clinical trials around the world for a number of diseases。
车辆管理的access

管理的access program

Novartis managed access makes investigational or unapproved treatments available to eligible patients with serious or life-threatening diseases.Your physician may request access。
入口和散热器保护

Diversity

Diversity in clinical trials helps us improve the quality of care for every patient，while also helping to address health inequities in society.We are working to improve both the diversity of patients enrolled in our clinical research and the investigators involved in our trials。

Collaborations with patient organizations

Japan ese doctor and patients discussing illness

Listening to the CML patient community

Improving the patient experience and removing potential barriers to clinical trial participation

读数，读数
Doctor with senior woman in an office

Patient organizations and Novartis

Working together with patient organizations and healthcare organizations helps us create better medicines.This collaboration is based on values of mutual respect，trust and transparency。

Learn more
men handshake_0

外部填充

Novartis may provide funding to电化时间，电化时间to support its mission to discover new ways to improve and extend people's live，advance scientific and medical knowledge，and supporting the communities where Novartis associates live and work。

Learn more
mother daughter hug

Patient perspectives

Patients and caregivers know better than anyone what it is like to live with a serious disease.Visit our YouTube channel to watch our patient stories to learn more about insights from the patient community。

Watch the videos

For questions about Novartis，medical inquiries about out our products and/or information about services，we recommend you contact the Novartis office in your country.If you’re seeking a global list of products，visit our Global Product Portfolio。

Country contacts
Novartis directory
全球产品出口
报告性能

*Based on 2022 data except for employees which has been restated to exclude Sandoz